Watson David O.

EDGAR CIK 0001657719

Apellis Pharmaceuticals, Inc. - APLS

Officer
General Counsel
Direct Buys
0
$0
0 Shares
Direct Sells
10
($1.15) M
-51,087 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
1
($523,400)
-20,000 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/22/2026
01/23/2026
Sell
-7,832 @ $21.77
($170,467) 88,531 (-8.13%) Direct
01/20/2026
01/21/2026
Sell
-2,475 @ $19.79
($48,987) 96,363 (-2.50%) Direct
01/13/2026
01/15/2026
Sell
-5,780 @ $22.19
($128,242) 98,838 (-5.52%) Direct
12/16/2025
12/18/2025
Sell
-5,000 @ $24.49
($122,450) 103,730 (-4.60%) Direct
11/17/2025
11/18/2025
Sell
-5,000 @ $20.06
($100,300) 108,730 (-4.40%) Direct
10/16/2025
10/17/2025
Sell
-5,000 @ $25.22
($126,100) 113,730 (-4.21%) Direct
09/16/2025
09/18/2025
Sell
-5,000 @ $24.34
($121,700) 118,730 (-4.04%) Direct
09/10/2025
09/12/2025
Sell
-20,000 @ $26.17
($523,400) 50,136 (-28.52%) Indirect - Indirect Owner (The David O. Watson Irrevocable Trust of 2023)
08/18/2025
08/19/2025
Sell
-5,000 @ $27.80
($139,000) 123,730 (-3.88%) Direct
07/16/2025
07/18/2025
Sell
-5,000 @ $19.55
($97,750) 128,730 (-3.74%) Direct
06/16/2025
06/18/2025
Sell
-5,000 @ $18.77
($93,850) 133,730 (-3.60%) Direct